Compare CVS Health Corp (CVS) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Palo Alto Networks Inc — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Palo Alto Networks Inc trades at $384.26 (market cap $313.81B). The key difference: Palo Alto Networks Inc is far larger — about 2.6× CVS Health Corp's market cap, and CVS Health Corp pays a 2.78% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.
| CVS | PANW | |
|---|---|---|
Market Cap | $122.36B | $313.81B |
Sector | Health | Technology |
52-Week High | $110.60 | $385.04 |
52-Week Low | $65.51 | $141.67 |
Enterprise Value | $184.71B | $312.77B |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Palo Alto Networks (PANW) trades at $363.86, up 1.22% today, near its pivot point of $365. The stock shows strong bullish momentum with consistent earnings beats and robust revenue growth, reaching $9.22 billion in fiscal 2025. Technical indicators signal bullish trends, while high valuation ratios like a P/E of 316.4 reflect market optimism. Recent news highlights AI-driven cybersecurity demand and record stock performance following industry events.
Outlook remains positive due to AI security tailwinds and earnings strength, but risks include premium valuation, integration costs from acquisitions, and regulatory scrutiny in China. Analyst consensus is strongly bullish with a $344.94 price target, though current price exceeds this, suggesting cautious optimism for growth-driven upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
